Only 34% of medical device applications get EU MDR approval. With 30% of SMEs locked out and extended deadlines to 2028, Europe's regulatory crisis is creating winners and losers. The question: Is your regulatory strategy turning chaos into competitive advantage—or leaving you behind? Discover how strategic companies are using extended timelines to dominate while others scramble.